These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
476 related items for PubMed ID: 34890373
1. Follow-up Study to Evaluate the Long-term Safety and Efficacy of Darvadstrocel (Mesenchymal Stem Cell Treatment) in Patients With Perianal Fistulizing Crohn's Disease: ADMIRE-CD Phase 3 Randomized Controlled Trial. Garcia-Olmo D, Gilaberte I, Binek M, D Hoore AJL, Lindner D, Selvaggi F, Spinelli A, Panés J. Dis Colon Rectum; 2022 May 01; 65(5):713-720. PubMed ID: 34890373 [Abstract] [Full Text] [Related]
2. A Phase IB/IIA Study of Ex Vivo Expanded Allogeneic Bone Marrow-Derived Mesenchymal Stem Cells for the Treatment of Perianal Fistulizing Crohn's Disease. Lightner AL, Reese J, Ream J, Nachand D, Jia X, Dadgar N, Steele SR, Hull T. Dis Colon Rectum; 2023 Oct 01; 66(10):1359-1372. PubMed ID: 36602511 [Abstract] [Full Text] [Related]
3. Efficacy and Safety of Treatment of Complex Idiopathic Fistula-in-Ano Using Autologous Centrifuged Adipose Tissue Containing Progenitor Cells: A Randomized Controlled Trial. Ascanelli S, Zamboni P, Campioni D, Grazia Sibilla M, Chimisso L, Zollino I, Valpiani G, Carcoforo P. Dis Colon Rectum; 2021 Oct 01; 64(10):1276-1285. PubMed ID: 34016825 [Abstract] [Full Text] [Related]
4. Safety of Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells for the Treatment of Complex Perianal Fistulas Not Associated With Crohn's Disease: A Phase I Clinical Trial. Maciel Gutiérrez VM, Gutiérrez Guillen SG, Centeno Flores MW, Valenzuela Pérez JA, Abarca Rendón FM, Hernández García FS, De la Cerda Trujillo LF, Gómez Torres GÁ. Dis Colon Rectum; 2021 Mar 01; 64(3):328-334. PubMed ID: 33538521 [Abstract] [Full Text] [Related]
5. Use of Darvadstrocel (Allogenic Stem Cell Therapy) for Crohn's Fistulas in Real Clinical Practice: The National Project to Implement Mesenchymal Stem Cell for the Treatment of Perianal Crohn's Fistula (the PRIME Study). Herreros MD, Ramirez JM, Otero-Piñeiro AM, Martí-Gallostra M, Badiola I, Enríquez-Navascues JM, Millan M, Barreiro EM, De La Portilla F, Suárez Alecha J, García-Olmo D, National Project to Implement Mesenchymal Stem Cell for the Treatment of Perianal Crohn’s Fistula (the PRIME Study) Group. Dis Colon Rectum; 2024 Jul 01; 67(7):960-967. PubMed ID: 38603800 [Abstract] [Full Text] [Related]
6. Durable Response in Patients With Refractory Fistulizing Perianal Crohn's Disease Using Autologous Mesenchymal Stem Cells on a Dissolvable Matrix: Results from the Phase I Stem Cell on Matrix Plug Trial. Dozois EJ, Lightner AL, Dietz AB, Fletcher JG, Lee YS, Friton JJ, Faubion WA. Dis Colon Rectum; 2023 Feb 01; 66(2):243-252. PubMed ID: 36538706 [Abstract] [Full Text] [Related]
7. A Prospective, Single-Arm Study to Evaluate the Safety and Efficacy of an Autologous Blood Clot Product in the Treatment of Anal Fistula. Ram E, Zager Y, Carter D, Saukhat O, Anteby R, Nachmany I, Horesh N. Dis Colon Rectum; 2024 Apr 01; 67(4):541-548. PubMed ID: 38149981 [Abstract] [Full Text] [Related]
8. Efficacy of Injection of Freshly Collected Autologous Adipose Tissue Into Complex Cryptoglandular Anal Fistulas. Dalby HR, Dige A, Pedersen BG, Krogh K, Agnholt J, Hougaard HT, Lundby L. Dis Colon Rectum; 2023 Mar 01; 66(3):443-450. PubMed ID: 36538700 [Abstract] [Full Text] [Related]
9. Long-term Outcomes of Perianal Fistulas in Pediatric Crohn's Disease. Vu JV, Kurowski JA, Achkar JP, Hull TL, Lipman J, Holubar SD, Steele SR, Lightner AL. Dis Colon Rectum; 2023 Jun 01; 66(6):816-822. PubMed ID: 36856689 [Abstract] [Full Text] [Related]
10. Initial Clinical Outcomes Using Umbilical Cord-Derived Tissue Grafts to Repair Anovaginal Fistula. Godoy-Brewer GM, Owodunni OP, Parian AM, Duraes LC, Selaru FM, Gearhart SL. Dis Colon Rectum; 2023 Feb 01; 66(2):299-305. PubMed ID: 35001050 [Abstract] [Full Text] [Related]
11. Short-term Results of Platelet-Rich Plasma in the Treatment of Chronic Anal Fissure: Randomized Controlled Clinical Study. Yilmaz G, Tanrikulu Y. Dis Colon Rectum; 2021 Jun 01; 64(6):714-723. PubMed ID: 33399410 [Abstract] [Full Text] [Related]
14. Efficacy and Safety of a Nonanimal Stabilized Hyaluronic Acid/Dextranomer in Improving Fecal Incontinence: A Prospective, Single-Arm, Multicenter, Clinical Study With 36-Month Follow-up. Quiroz LH, Galliano DE, da Silva G, Carmichael JC, Pan LC, Bromley ER, Hinahara JG, Goss TF. Dis Colon Rectum; 2023 Feb 01; 66(2):278-287. PubMed ID: 35001051 [Abstract] [Full Text] [Related]